22157.jpg
Global Anti-Infective Drugs Market to Recover by 2025 to Reach $158.29 Billion
23 sept. 2021 05h53 HE | Research and Markets
Dublin, Sept. 23, 2021 (GLOBE NEWSWIRE) -- The "Anti-Infective Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
Global Antibiotic Resistance Markets Report 2021: Therapeutic Technology Development Opportunities by Pathogen and Therapy Type 2020-2024
31 août 2021 05h53 HE | Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type 2020 to 2024" report has been added to ResearchAndMarkets.com's offering. ...
Summit logo.png
Summit Therapeutics Presents Breakthrough Research Data from Phase II Studies, including Evidence Validating Microbiome Preservation, for its Investigational Drug Ridinilazole
12 juil. 2021 08h29 HE | Summit Therapeutics Inc.
Cambridge, MA, July 12, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying three preeminent ePosters at the prestigious 31st European...
HelixBind_Logo_AS2-no BG (2018).png
HelixBind Awarded $3MM NIH Grant to Support Testing of Its RaPID Diagnostic Platform for Invasive Infections Associated with Sepsis
17 juin 2021 08h30 HE | HelixBind
BOXBOROUGH, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...
22157.jpg
Global Antibiotic Resistance Markets Report 2021 with Profiles of 100+ Biotechnology Companies
25 janv. 2021 05h08 HE | Research and Markets
Dublin, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type 2020 to 2024" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Antibiotics Technologies and Markets, 2025
12 janv. 2021 04h38 HE | Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Antibiotics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for antibiotics should...
22157.jpg
Global Antibiotic Resistance Markets to 2024: Examine 6 Key Opportunity Areas
01 oct. 2020 04h09 HE | Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type 2020 To 2024" report has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Global Antibiotic Resistance Markets Report 2020: Analysis and Forecasts 2017-2019 & 2020-2023 with Profiles of 100+ Companies
30 sept. 2020 04h29 HE | Research and Markets
Dublin, Sept. 30, 2020 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics By Pathogen and Therapy Type With Situation Analysis, Executive & Investor Guides & Customization...
HelixBind_Logo_AS2-no BG (2018).png
FDA Grants HelixBind Breakthrough Device Designation for RaPID Sepsis Test
24 août 2020 11h47 HE | HelixBind
BOXBOROUGH, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) -- HelixBind, which is developing an innovative diagnostic platform to revolutionize care for invasive infections such as sepsis, announced today it...
Professor Gordon Dou
Professor Gordon Dougan Receives the 2020 Albert B. Sabin Gold Medal
13 août 2020 10h00 HE | The Sabin Vaccine Institute
Washington, D.C., Aug. 13, 2020 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced that it has awarded its annual Albert B. Sabin Gold Medal to Gordon Dougan, FRS, professor in...